Skip to main content

Together we are beating cancer

Donate now

Search Results: BRCA

Showing 12 out of 270 results
PARP and inhibitor

Research by our scientists played a major part in the development of a promising new class of cancer drugs. So where are we now in this research journey? Research by our scientists played a major part in the development of a promising new class of cancer drugs. So where are we now in this research journey?

by Justine Alford | Analysis | 12 September 2016

12 September 2016

This entry is part 5 of 5 in the series Google Hangouts
%postcontent%
  • Science & Technology
  • Health & Medicine

Dundee research explains drug resistance in ovarian cancer

Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments. Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments.

by British Journal of Cancer | News | 10 August 2016

10 August 2016

Why aren't we sharing?
  • For Researchers

Why aren’t we sharing?

We caught up with three of our researchers to find out why they’ve placed data sharing at the heart of their research programmes. We caught up with three of our researchers to find out why they’ve placed data sharing at the heart of their research programmes.

by Cancer Research UK | Research Feature | 10 August 2016

10 August 2016

Tomas Lindahl

We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this. We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this.

by Cancer Research UK | Research Feature | 10 August 2016

10 August 2016

We explore our seventh Grand Challenge, attempting to pull off the ultimate cell heist and use new 'smart drugs' to selectively kill cancer cells. We explore our seventh Grand Challenge, attempting to pull off the ultimate cell heist and use new 'smart drugs' to selectively kill cancer cells.

by Aine McCarthy | Analysis | 2 February 2016

2 February 2016